Physician profile
Philip Andrew Utter
NPI 1073585477
$3,584.29
in general payments reported to CMS, 2019-2025
15 companies · $42.09 in 2025
The $42.09 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $86.85 · 2021: $118 · 2022: $435 · 2023: $1,595 · 2024: $415 · 2025: $42.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,340 · Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,340.01 |
| Food and Beverage | $712.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,388.03 | 2023 | Teligen |
| Kuros Biosciences USA, INC | $434.54 | 2022 | |
| Centinel Spine, LLC | $411.67 | 2019 | |
| Biedermann Motech, INC. | $281.59 | 2019-2023 | Moss Vrs Mis Spinal System |
| Depuy Synthes Sales INC. | $267.44 | 2020-2024 | Conduit, X-Pac, Acis Proti 360 Hl |
| Providence Medical Technology, INC. | $213.88 | 2024 | |
| Boston Scientific Corporation | $167.18 | 2024 | |
| Titan Spine, LLC | $137.26 | 2019 | |
| Globus Medical, INC. | $95.15 | 2019 | |
| Intrinsic Therapeutics | $93.48 | 2020-2021 | |
| Xtant Medical INC | $24.55 | 2025 | |
| Stryker Corporation | $20.03 | 2020 | |
| Medtronic, INC. | $17.54 | 2025 | Aquamantys(Tm) |
| Medtronic USA, INC. | $16.51 | 2020 | |
| Ethicon US, LLC | $15.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Utter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.